Latest NewsSee the Latest News from Isoray.Latest News | Press Releases | BlogMedia & Public Relations InquiriesPlease contact Sharon Schultz Public and Media Relations T: 302.539.3747 | EmailMedia & Public Relations InquiriesContact Sharon Schultz, using the form below. <a href="https://isoray.wufoo.com/forms/r11wv74f0yjnsea/" target="_blank" rel="noopener noreferrer">Fill out my Wufoo form!</a> Prostate Cancer News Today: “Prostate Cancer Patients Treated with Radioactive Seeds Retain Urinary, Bowel Quality”06/14/2018U.S. News & World Report: Cesium-131 featured in “10 Innovations in Cancer Therapy”05/16/2018Isoray Nasdaq Market Site Interview with Tom LaVoy, Chairman and CEO, November 26, 201712/07/2017WKYT: “Lexington cancer doctor saving women’s lives”07/18/2017IsoRay CEO Thomas LaVoy Talks The Future Of Cesium-131 Brachytherapy With The Wall Street Transcript06/26/2017New guidelines and targeted treatment: insights from AUA 201706/01/2017Prostate Cancer News Today: “Prostate Cancer Patients Treated with Radioactive Seeds Retain Urinary, Bowel Quality”05/16/2017Developing Seed Brachytherapy and Medical Radioisotope Applications for the Treatment of Multiple Cancers12/28/20164 12 5
Prostate Cancer News Today: “Prostate Cancer Patients Treated with Radioactive Seeds Retain Urinary, Bowel Quality”06/14/2018
IsoRay CEO Thomas LaVoy Talks The Future Of Cesium-131 Brachytherapy With The Wall Street Transcript06/26/2017
Prostate Cancer News Today: “Prostate Cancer Patients Treated with Radioactive Seeds Retain Urinary, Bowel Quality”05/16/2017
Developing Seed Brachytherapy and Medical Radioisotope Applications for the Treatment of Multiple Cancers12/28/2016
